Thus, it is inaccurate to describe MpBC as chemoresistant because the responsiveness to such therapy should be evaluated considering various factors, such as tumor size, nodal status, nuclear and histologic grade, and Ki-67. The gene discussed is MKI67; the disease is neoplasm.